A Randomized, Open-Label Study of the Effect of MabThera Plus Chemotherapy Versus Chemotherapy Alone on Clinical Response in Patients With Indolent Non-Hodgkin's and Mantle Cell Lymphoma.
Latest Information Update: 30 Jul 2015
At a glance
- Drugs Rituximab (Primary) ; Chlorambucil; Mitoxantrone; Prednisolone
- Indications Follicular lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 05 May 2009 Actual patients number changed from 358 to 368 as reported by ClinicalTrials.gov.
- 09 Apr 2007 Status changed from in progress to completed.
- 09 Apr 2007 Results published in JCO.